Common confounder could skew biologic trials


The outcomes of many clinical trials involving the use of biologics in rheumatoid arthritis could be skewed because they overlook the socio-economic status of patients, researchers say. Writing in a letter published in Rheumatology the team of researchers led by Dr Helen Benham from the University of Queensland said it was well known that lower ...


Already a member? Login to keep reading


OR
© 2017 the limbic